コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 inhibitors and integrase inhibitors (without cobicistat).
2 xed-dose tablet containing darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg, and tenofovir a
3 ingle-tablet containing elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg, and tenofovir a
4 ose oral formulation of elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg, and tenofovir a
5 blets containing 150 mg elvitegravir, 150 mg cobicistat, 200 mg emtricitabine, and 10 mg tenofovir al
6 arer) containing 150 mg elvitegravir, 150 mg cobicistat, 200 mg emtricitabine, and 10 mg tenofovir al
7 fumarate (DF) plus emtricitabine, and either cobicistat-boosted elvitegravir (EVGcobi), rilpivirine (
9 been co-formulated with the CYP3A4 inhibitor cobicistat (COBI), emtricitabine (FTC), and tenofovir di
10 been co-formulated with the CYP3A4 inhibitor cobicistat (COBI), emtricitabine (FTC), and tenofovir di
11 emtricitabine (FTC), the quad pill includes cobicistat (COBI; an inactivator of cytochrome P450 isoe
12 e P450 3A4 (CYP3A4) inhibitors ritonavir and cobicistat, currently administered to HIV patients as ph
13 ing) to switch to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir (switch group)
14 ety and efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide as
15 let, fixed-dose combination of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in
16 let, fixed-dose combination of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide is
19 ing to a single-tablet regimen of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide ver
20 The fixed-dose combination of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide was
22 e inhibitor regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fuma
23 the initiation of therapy with elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fuma
24 omly assigned (1:1) to receive elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fuma
27 ther to switch to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir or to continue
30 which compared the efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。